Latanoprost/Timolol Eg

Latanoprost and Timolol, the active ingredients in Latanoprost/Timolol Eg, are a prostaglandin analog and beta‑blocker combination presented as eye drops for ocular use. It treats open‑angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost/Timolol Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol Eg is used in the management of ocular conditions that require reduction of intra‑ocular pressure. - Open‑angle glaucoma: lowers intra‑ocular pressure to prevent optic nerve damage. - Ocular hypertension: reduces elevated eye pressure to lower the risk of developing glaucoma. - Secondary open‑angle glaucoma: assists in controlling pressure when glaucoma is associated with other ocular diseases.

The following adverse reactions have been reported with Latanoprost/Timolol eye drops.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision shortly after instillation. - Conjunctival hyperemia (red eye). - Itching or mild allergic response on the eyelid. - Dry eye or foreign‑body sensation. - Increased eyelash growth.

Serious or Rare Side Effects: - Severe allergic reaction (angio‑edema, anaphylaxis). - Worsening of glaucoma or sudden loss of vision. - Chest pain or marked bradycardia. - Bronchospasm or severe respiratory difficulty. - Persistent eye pain or corneal ulceration. - Vision loss requiring immediate medical attention.

Before using Latanoprost/Timolol eye drops, consider the following precautions. - Pregnancy: safety not established; use only if potential benefit justifies the risk. - Breastfeeding: unknown excretion in milk; weigh benefits against possible risks. - Respiratory disease: avoid in patients with asthma or chronic obstructive pulmonary disease. - Cardiovascular disease: monitor heart rate and blood pressure; contraindicated in severe bradycardia. - Drug interactions: be cautious when co‑administering other beta‑blockers or prostaglandin analogues. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost/Timolol may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers: additive bradycardia and hypotension. - Other intra‑ocular pressure‑lowering prostaglandin analogues: risk of excessive pressure reduction. - Asthma or COPD reliever inhalers (β‑agonists): may diminish therapeutic effect.

Moderate Interactions (Monitor Closely): - Systemic antihypertensives: monitor for enhanced hypotensive response. - Calcium channel blockers: observe for bradycardia. - Anticholinergic eye drops: may affect ocular surface tolerance. - Topical ocular anesthetics: potential for delayed wound healing.